Labcorp Holdings Price to Book Ratio 2012-2025 | LH
Historical price to book ratio values for Labcorp Holdings (LH) over the last 10 years. The current price to book ratio for Labcorp Holdings as of January 14, 2026 is 2.50.
| Labcorp Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-15 | 268.89 | 2.57 | |
| 2025-09-30 | 286.29 | $104.78 | 2.73 |
| 2025-06-30 | 261.14 | $102.20 | 2.56 |
| 2025-03-31 | 230.85 | $99.13 | 2.33 |
| 2024-12-31 | 226.80 | $96.55 | 2.35 |
| 2024-09-30 | 220.37 | $97.61 | 2.26 |
| 2024-06-30 | 200.05 | $95.53 | 2.09 |
| 2024-03-31 | 213.96 | $94.42 | 2.27 |
| 2023-12-31 | 221.88 | $93.86 | 2.36 |
| 2023-09-30 | 195.59 | $92.73 | 2.11 |
| 2023-06-30 | 201.01 | $99.04 | 2.03 |
| 2023-03-31 | 190.46 | $116.72 | 1.63 |
| 2022-12-31 | 194.92 | $114.47 | 1.70 |
| 2022-09-30 | 169.04 | $112.64 | 1.50 |
| 2022-06-30 | 192.89 | $114.29 | 1.69 |
| 2022-03-31 | 216.37 | $115.40 | 1.87 |
| 2021-12-31 | 257.86 | $110.35 | 2.34 |
| 2021-09-30 | 230.96 | $109.86 | 2.10 |
| 2021-06-30 | 226.38 | $105.95 | 2.14 |
| 2021-03-31 | 209.29 | $102.47 | 2.04 |
| 2020-12-31 | 167.04 | $96.79 | 1.73 |
| 2020-09-30 | 154.50 | $84.59 | 1.83 |
| 2020-06-30 | 136.32 | $75.57 | 1.80 |
| 2020-03-31 | 103.72 | $72.30 | 1.43 |
| 2019-12-31 | 138.83 | $77.85 | 1.78 |
| 2019-09-30 | 137.87 | $74.24 | 1.86 |
| 2019-06-30 | 141.89 | $73.05 | 1.94 |
| 2019-03-31 | 125.54 | $72.05 | 1.74 |
| 2018-12-31 | 103.70 | $70.49 | 1.47 |
| 2018-09-30 | 142.53 | $71.48 | 1.99 |
| 2018-06-30 | 147.33 | $69.00 | 2.14 |
| 2018-03-31 | 132.74 | $68.40 | 1.94 |
| 2017-12-31 | 130.90 | $66.77 | 1.96 |
| 2017-09-30 | 123.89 | $60.00 | 2.06 |
| 2017-06-30 | 126.49 | $57.63 | 2.19 |
| 2017-03-31 | 117.74 | $55.08 | 2.14 |
| 2016-12-31 | 105.35 | $53.61 | 1.97 |
| 2016-09-30 | 112.82 | $53.73 | 2.10 |
| 2016-06-30 | 106.91 | $51.99 | 2.06 |
| 2016-03-31 | 96.12 | $50.60 | 1.90 |
| 2015-12-31 | 101.47 | $48.82 | 2.08 |
| 2015-09-30 | 89.02 | $48.55 | 1.83 |
| 2015-06-30 | 99.48 | $47.32 | 2.10 |
| 2015-03-31 | 103.48 | $44.95 | 2.30 |
| 2014-12-31 | 88.55 | $33.34 | 2.66 |
| 2014-09-30 | 83.50 | $32.64 | 2.56 |
| 2014-06-30 | 84.03 | $31.29 | 2.69 |
| 2014-03-31 | 80.60 | $29.50 | 2.73 |
| 2013-12-31 | 74.98 | $29.07 | 2.58 |
| 2013-09-30 | 81.36 | $29.22 | 2.78 |
| 2013-06-30 | 82.15 | $29.43 | 2.79 |
| 2013-03-31 | 74.02 | $29.94 | 2.47 |
| 2012-12-31 | 71.08 | $29.06 | 2.45 |
| 2012-09-30 | 75.89 | $28.63 | 2.65 |
| 2012-06-30 | 76.00 | $27.47 | 2.77 |
| 2012-03-31 | 75.12 | $26.75 | 2.81 |
| 2011-12-31 | 70.55 | $25.60 | 2.76 |
| 2011-09-30 | 64.87 | $25.51 | 2.54 |
| 2011-06-30 | 79.43 | $25.44 | 3.12 |
| 2011-03-31 | 75.61 | $23.96 | 3.16 |
| 2010-12-31 | 72.15 | $24.09 | 3.00 |
| 2010-09-30 | 64.36 | $22.32 | 2.88 |
| 2010-06-30 | 61.84 | $21.43 | 2.89 |
| 2010-03-31 | 62.13 | $20.71 | 3.00 |
| 2009-12-31 | 61.42 | $20.00 | 3.07 |
| 2009-09-30 | 53.92 | $19.05 | 2.83 |
| 2009-06-30 | 55.63 | $18.47 | 3.01 |
| 2009-03-31 | 48.00 | $16.79 | 2.86 |
| 2008-12-31 | 52.86 | $15.60 | 3.39 |
| 2008-09-30 | 57.03 | $15.37 | 3.71 |
| 2008-06-30 | 57.14 | $16.19 | 3.53 |
| 2008-03-31 | 60.47 | $15.30 | 3.95 |
| 2007-12-31 | 61.98 | $15.54 | 3.99 |
| 2007-09-30 | 64.20 | $17.09 | 3.76 |
| 2007-06-30 | 64.22 | $16.41 | 3.91 |
| 2007-03-31 | 59.60 | $15.20 | 3.92 |
| 2006-12-31 | 60.29 | $16.18 | 3.73 |
| 2006-09-30 | 53.81 | $17.11 | 3.15 |
| 2006-06-30 | 51.07 | $16.07 | 3.18 |
| 2006-03-31 | 47.99 | $14.99 | 3.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.720B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.076B | 30.86 |
| HCA Healthcare (HCA) | United States | $109.268B | 18.09 |
| CVS Health (CVS) | United States | $100.704B | 11.58 |
| Elevance Health (ELV) | United States | $82.860B | 12.15 |
| Cencora (COR) | United States | $67.884B | 21.88 |
| Natera (NTRA) | United States | $33.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Medpace Holdings (MEDP) | United States | $17.364B | 43.11 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.188B | 0.00 |
| Viatris (VTRS) | United States | $15.146B | 5.64 |
| ICON (ICLR) | Ireland | $14.921B | 14.81 |
| BioMerieux (BMXMF) | France | $14.304B | 0.00 |
| Solventum (SOLV) | United States | $13.884B | 13.48 |
| Revvity (RVTY) | United States | $12.644B | 23.28 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.650B | 20.51 |
| Avantor (AVTR) | United States | $8.441B | 12.90 |
| Sonic Healthcare (SKHHY) | Australia | $7.636B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.454B | 0.00 |
| HealthEquity (HQY) | United States | $7.313B | 27.35 |
| BrightSpring Health Services (BTSG) | United States | $6.935B | 41.34 |
| PACS (PACS) | United States | $6.185B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $6.135B | 40.28 |
| Sotera Health (SHC) | United States | $5.452B | 26.29 |
| Alignment Healthcare (ALHC) | United States | $4.351B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.022B | 53.08 |
| Concentras Parent (CON) | United States | $2.619B | 16.34 |
| Progyny (PGNY) | United States | $2.252B | 44.27 |
| Organon (OGN) | United States | $2.238B | 2.36 |
| Surgery Partners (SGRY) | United States | $1.993B | 25.68 |
| Establishment Labs Holdings (ESTA) | United States | $1.923B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.891B | 11.29 |
| Ardent Health (ARDT) | United States | $1.244B | 4.06 |
| Nutex Health (NUTX) | United States | $1.173B | 8.97 |
| Teladoc Health (TDOC) | United States | $1.173B | 0.00 |
| CareDx (CDNA) | United States | $1.045B | 17.08 |
| GoodRx Holdings (GDRX) | United States | $0.933B | 15.28 |
| Omada Health (OMDA) | United States | $0.898B | 0.00 |
| Embecta (EMBC) | United States | $0.755B | 4.29 |
| InnovAge Holding (INNV) | United States | $0.752B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.733B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.547B | 24.55 |
| CryoPort (CYRX) | United States | $0.545B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.481B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 8.40 |
| Agilon Health (AGL) | United States | $0.402B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.52 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.279B | 0.00 |
| So-Young (SY) | China | $0.272B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.255B | 53.65 |
| KindlyMD (NAKA) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| LifeMD (LFMD) | United States | $0.185B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |